EU drug regulator: Unusual blood clot is ‘very rare AstraZeneca side effect’

After a virtual meeting of EU health ministers on Wednesday to discuss the EMA findings, European Commissioner for Health Stella Kyriakides said in a statement: “Our decisions should now be based on the scientific work of EMA, and a rigorous, continuous assessment of risks and benefits.